A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Letermovir USP Related Compound B | CAS 2991059-71-1 - Request Quote

Picture of Letermovir USP Related Compound B

Letermovir USP Related Compound B

SZ CAT No: SZ-L052020
CAS No
2991059-71-1
Mol.F.
C29H28F4N4O5
Mol.Wt.
588.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

CHNS Ratio (%) :

Usage Note:

Letermovir USP Related Compound B is chemically (S)-4-{4-(Carboxymethyl)-8-fluoro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-2-yl}-1-(3-methoxyphenyl)piperazine 1-oxide (as per USP). Letermovir USP Related Compound B is supplied with detailed characterization data compliant with regulatory guideline. Letermovir USP Related Compound B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Letermovir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2991059-71-1

Purchase 2991059-71-1

Order 2991059-71-1

Enquire 2991059-71-1

price of 2991059-71-1

2991059-71-1 Supplier

2991059-71-1 Manufacturer

2991059-71-1 Exporter

buy high quality Letermovir USP Related Compound B

Purchase Letermovir USP Related Compound B

Letermovir USP Related Compound B suppliers

Letermovir USP Related Compound B manufacturers

Letermovir USP Related Compound B price

Order Letermovir USP Related Compound B

Enquire Letermovir USP Related Compound B

Letermovir USP Related Compound B cost

Letermovir USP Related Compound B Supplier

Letermovir USP Related Compound B Distributor

Letermovir USP Related Compound B for Method Validation

Letermovir Reference Standard

Letermovir USP Related Compound B for ANDA Filing

Letermovir USP Related Compound B for Forced Degradation Studies

Letermovir USP Related Compound B Identification Standards

Letermovir USP Related Compound B for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

Notice

Date:

Location: